This inventor holds 3 USPTO granted patents. Top assignee: Unitika Ltd.. Active years: 1992-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992-1993
Title: Akira Takeda: Innovator in Thermostable Lipoprotein Lipase Technology
Introduction
Akira Takeda is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of reagents for determining triglycerides. With a total of 3 patents to his name, Takeda's work has the potential to impact medical diagnostics and treatment.
Latest Patents
Takeda's latest patents include a reagent for determining triglycerides that comprises a thermostable lipoprotein lipase obtained from Streptomyces 7825. This reagent composition is designed to effectively determine blood triglycerides by utilizing a color former and a thermostable lipoprotein lipase. Another notable patent focuses on the method for producing this thermostable lipoprotein lipase, which is capable of hydrolyzing triglycerides in lipoproteins to glycerol and fatty acids. The thermostable lipoprotein lipase exhibits remarkable retention of hydrolyzing activity under specific conditions, showcasing its potential for practical applications in medical diagnostics.
Career Highlights
Akira Takeda is associated with Unitika Ltd., where he has been able to apply his innovative ideas in a collaborative environment. His work has garnered attention for its practical implications in the field of biochemistry and medical diagnostics.
Collaborations
Takeda has worked alongside notable colleagues, including Tomoko Kamei and Masao Kageyama. Their collaborative efforts have contributed to the advancement of research in the field of lipoprotein lipase technology.
Conclusion
Akira Takeda's contributions to the field of biochemistry, particularly through his innovative patents, highlight his role as a key inventor in the development of medical diagnostic tools. His work continues to pave the way for advancements in the understanding and treatment of triglyceride-related health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
